Health
Cancer risk rises with this little-known syndrome. Here’s how to know if you have the genetic condition
As colorectal cancer continues to spike among younger patients, doctors are warning of a little-known but widespread condition that greatly increases the risk.
Lynch syndrome is a genetic disorder that makes someone more susceptible to many different kinds of cancer.
Fox News Digital spoke with two experts about what people should know about this inherited condition.
CANCER PREVENTION IN THE ESOPHAGUS COULD BE JUST A PILL AWAY, DOCTOR SAYS: ‘TREMENDOUS BENEFIT’
Dr. Matthew Grossman, an interventional endoscopist and gastroenterologist with Atlantic Health System in New Jersey, explained the relationship between Lynch syndrome and human DNA.
“Think of DNA as a ladder,” he said. “Normally, errors in the rungs — called mismatches — are fixed by a repair system. In Lynch syndrome, this system is faulty, increasing the risk of mismatches.”
Lynch syndrome is a genetic disorder that makes someone more susceptible to many different kinds of cancer. (iStock)
Because of the mismatch repair defect, a person with Lynch syndrome is much more likely to develop abnormalities and defects in cells, which eventually lead to cancer, he said.
“Lynch syndrome is a type of germline mutation, meaning it’s inherited genetically, versus a somatic mutation, which can happen spontaneously to only a few cells,” said Grossman.
DOCTORS TOLD WOMAN SHE WAS TOO YOUNG FOR A COLONOSCOPY. THEN SHE WAS DIAGNOSED WITH STAGE 3 COLON CANCER
Dr. Ajay Bansal, a gastroenterologist at KU Medical Center at the University of Kansas, emphasized that Lynch syndrome largely flies under the radar, as 95% of patients who have the condition don’t know about it.
“They are not aware that they are at increased risk for not only colon cancer, but also uterine, ovarian, stomach, small bowel, kidney, bladder and perhaps brain cancer,” he told Fox News Digital. “So it’s very underdiagnosed.”
In healthy DNA, errors in the rungs — called mismatches — are fixed by a repair system. In Lynch syndrome, the repair system is faulty, increasing the risk of mismatches, a doctor explained. (iStock)
One of the reasons the syndrome often goes unnoticed is because it’s a “silent” condition, Bansal said. “It doesn’t cause any symptoms until you have cancer.”
The two main cancers tied to the syndrome are colon and colorectal cancer and cancer of the uterus.
“Lynch syndrome can result from four or five different mutations,” Bansal said. “Depending on the mutation, the type of cancer risk changes.”
COLORECTAL CANCER IS NOW LEADING CAUSE OF DEATH AMONG YOUNG ADULTS WITH CANCER: NEW REPORT
For example, for those who have a mutation in a gene called MLH1, the risk of getting colorectal cancer at some point in their lifetime is 80%, Bansal warned.
Among young-onset colorectal cancers, the doctor estimated that roughly 25% are a result of Lynch syndrome.
How is Lynch syndrome detected?
Lynch syndrome can be diagnosed by either a blood test or saliva test, Bansal said.
“If a patient has a family history of multiple colon cancers or multiple other cancers in the family, or if somebody in the family had colon cancer or uterine cancer under the age of 50, we recommend genetic testing to confirm the syndrome,” he said.
Lynch syndrome can be diagnosed through either a blood test or saliva test. (iStock)
Patients who fall into these categories are typically tested for Lynch between the ages of 18 to 25, the doctor said.
Universal genetic testing is not generally performed.
“It’s not approved for the general population, mainly because of costs and insurance concerns,” Bansal noted.
CANCER RISK COULD INCREASE WITH CONSUMPTION OF CERTAIN FOODS AND DRINKS, STUDY FINDS
Before genetic testing was available, clinicians relied on the “3,2,1 criteria” for diagnosing Lynch syndrome, according to Grossman.
“For that criteria, if patients have three or more relatives with one of the affecting cancers on the same side of the family, and this is seen in two or more generations with at least one person under age 50, that is highly diagnostic of Lynch syndrome and they should discuss the condition with a doctor,” he said.
What happens if you’re diagnosed?
There is no treatment or “cure” for Lynch syndrome, as it’s caused by a genetic mutation.
Those who test positive should closely monitor themselves for the warning signs of cancer through regular screenings — especially colonoscopies, Bansal said.
Patients should talk to their primary care doctors about their family history, a doctor advised. (iStock)
In the general population, among people without Lynch syndrome, it is recommended to start colonoscopies at the age of 45.
In patients with Lynch syndrome — especially those with more aggressive phenotypes and genotypes — Bansal recommended starting colonoscopies at the age of 25 and repeating them every one to two years.
“The idea here would be to monitor closely so we can prevent colon cancer by removing polyps or catching it at an early stage when we can treat it,” he said.
CANCER SCREENINGS: HERE ARE 5 TYPES AND CRITICAL INFORMATION TO KNOW ABOUT EACH
Bansal, who specializes in studying vaccines for cancer prevention, is currently running a clinical trial for a new cancer vaccine. The participants are all people with Lynch syndrome.
“We felt that we had to do something to change the natural history of cancer in this high-risk population,” he told Fox News Digital.
In the trial, researchers are testing a combination of three vaccines that were initially created by a scientist at the National Cancer Institute.
“If a patient has a family history of multiple colon cancers or multiple other cancers in the family, or if somebody in the family had colon cancer or uterine cancer under the age of 50, we recommend genetic testing to confirm the syndrome,” a doctor said. (iStock)
“These vaccines attack those cells in the colorectal area that express abnormal proteins, and then it can train the immune cells to get rid of those cells in the colon — and perhaps in other organs such as the stomach, small bowel, pancreas and uterus — before they turn into cancer or polyps.”
The first two safety phases of the trial have already been completed.
Next, the researchers will perform randomized controlled trials to gauge the effectiveness of the vaccines in keeping cancer at bay.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
If the trial is successful, Bansal said he envisions the vaccine extending to other types of cancers.
Bansal’s main advice to patients is to talk to their primary care doctors about their family history.
The two main cancers tied to the syndrome are colon and colorectal cancer and cancer of the uterus. (iStock)
“In medical care, everybody’s so busy that we don’t discuss family history enough,” he said. “Patients should ask their doctor about their family history of cancers and the possibility of genetic testing, which has become much cheaper than ever before.”
Grossman agreed that it’s important to be aware of the risks associated with the genetic condition.
“Knowing you have Lynch syndrome allows for more frequent colonoscopies and additional cancer screenings that will help save lives,” he said.
“This is a great example of how our increased knowledge of genetics has improved our clinical care.”
For more Health articles, visit www.foxnews.com/health.
Health
Brain aging may accelerate after cancer treatment, study suggests
NEWYou can now listen to Fox News articles!
Surviving cancer as a child or young adult may have a lasting impact on aging, new research suggests.
Researchers at the University of Rochester Medical Center looked at whether life-saving treatments, like chemotherapy and radiation, could speed up biological aging.
They also aimed to determine whether this age acceleration was linked to cognitive issues related to memory, focus and learning.
The team analyzed blood samples from a group of 1,400 long-term survivors treated at St. Jude Children’s Research Hospital, using epigenetic clocks — tools that estimate biological age by examining chemical tags on DNA.
Biological age is determined based on damage the cells accumulate over time, versus chronological age, which is measured by how long someone has been alive, according to scientists.
Biological age is determined based on the damage cells accumulate over time, according to scientists. (iStock)
“These well-established aging-related biomarkers have previously been associated with neurocognitive impairment and decline in older non-cancer populations, particularly in cognitive domains related to aging and dementia, such as memory, attention and executive function,” the study stated.
Most of the group consisted of acute lymphoblastic leukemia survivors, or Hodgkin lymphoma survivors. Participants were at least five years past their treatment, though some had survived for several decades.
They underwent neurocognitive testing to measure their attention span, memory and information processing speed.
CREATIVE HOBBIES KEEP THE BRAIN YOUNG, STUDY FINDS — HERE ARE THE BEST ONES TO PURSUE
Chemotherapy was found to have the greatest impact on aging acceleration. The study suggests the treatment can alter DNA structure and cause cellular damage.
CLICK HERE FOR MORE HEALTH STORIES
“It’s no surprise to find out that young people with cancer who have chemo early in life are affected in terms of long-term aging,” Dr. Marc Siegel, senior medical analyst for Fox News, told Fox News Digital.
Participants underwent neurocognitive testing to measure their attention span, memory and speed of information processing. (iStock)
Researchers also found that cellular aging was closely linked to cognitive performance, as survivors of a higher biological age had more difficulty with memory and attention.
“Chemo poisons and damages cellular function — hopefully the cancer cells more than normal cells, but there is a significant impact on normal cells as well,” said Siegel, who was not involved in the study.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“There is also something called ‘chemo brain,’ which causes at least temporary difficulty with memory, concentration, word finding and brain fog,” the doctor added.
The research team hopes to use these findings to focus on intervention efforts, specifically by determining when accelerated aging begins.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“Young cancer survivors have many more decades of life to live,” lead study author AnnaLynn Williams, PhD, said in a press release. “If these accelerated aging changes are occurring early on and setting them on a different trajectory, the goal is to intervene to not only increase their lifespan, but improve their quality of life.”
The team hopes this research will help in the development of early intervention tools that aim to prevent cognitive decline. (iStock)
There were some limitations to the study. The researchers could not adjust for chronic health conditions or education because they are directly impacted by treatment.
Additionally, the study only looked at the survivors at a single point of time, so it could not directly prove causation.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
The study was published in the journal Nature Communications.
Fox News Digital reached out to the researchers for comment.
Health
GLP-1 Drugs Linked to Osteoporosis and Gout: Here’s How To Stay Safe
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Health
Ozempic-style drugs could slash complication risks after heart attacks, research suggests
NEWYou can now listen to Fox News articles!
A popular class of weight-loss drugs may prevent life-threatening cardiac complications by opening microscopic blood vessels that often remain blocked after a heart attack, according to a study published this week in Nature Communications.
The research, led by the University of Bristol and University College London, identified a biological brain-gut-heart signaling pathway.
This discovery appears to explain how GLP-1 drugs — which mimic glucagon-like peptide-1, a hormone that helps regulate blood sugar and appetite — protect heart tissue from a condition known as “no-reflow.”
“In nearly half of all heart attack patients, tiny blood vessels within the heart muscle remain narrowed, even after the main artery is cleared during emergency medical treatment,” Dr. Svetlana Mastitskaya, the study’s lead author and a senior lecturer at Bristol Medical School, said in a press release.
“This results in a complication known as ‘no-reflow,’ where blood is unable to reach certain parts of the heart tissue.”
In nearly half of all heart attack patients, tiny capillaries (blood vessels) remain narrowed even after the main blocked artery is cleared. (iStock)
This lack of blood flow increases the risk of heart failure and death within a year. GLP-1 medications could prevent this, according to the researchers.
How it works
When the GLP-1 hormone is released in the gut or administered as a drug, it sends a signal to the brain, which then sends a signal to the heart that switches on special potassium channels in tiny cells called pericytes.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
When these channels open, the pericytes relax, which allows the small blood vessels (capillaries) to widen and improve blood flow to the heart muscle, the researchers noted.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The new study used animal models and cellular imaging to track how GLP-1 interacts with heart tissue. When the researchers removed the potassium channels, the drugs no longer protected the heart — confirming they play a key role.
The findings suggest that existing GLP-1 medications, already used for type 2 diabetes and obesity, could be repurposed as emergency treatments. (iStock)
The findings suggest that existing GLP-1 medications, already used for type 2 diabetes and obesity, could be repurposed as emergency treatments during or immediately after a heart attack to reduce tissue damage.
CLICK HERE FOR MORE HEALTH STORIES
The researchers noted several limitations, including that the study relied on animal models.
Clinical trials are necessary to determine whether the brain-gut-heart pathway operates with the same timing and efficacy in humans.
While the study highlights the drug’s immediate benefits during a heart attack, it des not establish whether long-term use of these drugs provides a pre-existing level of protection. (iStock)
Additionally, while the study highlights the drug’s immediate benefits during a heart attack, it does not establish whether long-term use of the medication provides a pre-existing level of protection.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
The research was primarily funded by the British Heart Foundation.
-
World1 week agoExclusive: DeepSeek withholds latest AI model from US chipmakers including Nvidia, sources say
-
Wisconsin4 days agoSetting sail on iceboats across a frozen lake in Wisconsin
-
Massachusetts3 days agoMassachusetts man awaits word from family in Iran after attacks
-
Massachusetts1 week agoMother and daughter injured in Taunton house explosion
-
Maryland5 days agoAM showers Sunday in Maryland
-
Florida5 days agoFlorida man rescued after being stuck in shoulder-deep mud for days
-
Denver, CO1 week ago10 acres charred, 5 injured in Thornton grass fire, evacuation orders lifted
-
Oregon7 days ago2026 OSAA Oregon Wrestling State Championship Results And Brackets – FloWrestling